Dipòsit Digital de Documents de la UAB 41 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.02 segons. 
1.
10 p, 3.3 MB Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia : results of the BURKIMAB14 trial / Ribera, Josep Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Morgades, Mireia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Garcia-Calduch, Olga (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sirvent, Maialen (Hospital Universitario de Donostia) ; Buendia, Buenaventura (Hospital Universitario 12 de Octubre) ; Cervera, Marta (Institut Catala d'Oncologia-Hospital Joan XXIII) ; Luzardo, Hugo (Hospital Universitario de Gran Canaria Dr. Negrin) ; Hernandez-Rivas, Jesus Maria (Hospital Universitario de Salamanca) ; Sitges, Marta (Institut Catala d'Oncologia-Hospital Josep Trueta) ; Garcia-Cadenas, Irene (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Abrisqueta, Pau (Hospital Universitari Vall d'Hebron) ; Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ; Bastos-Oreiro, Mariana (Hospital General Universitario Gregorio Marañón) ; De Llano, Maria Paz Queipo (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Bravo, Pilar (Hospital Universitario de Fuenlabrada. Madrid) ; Torrent, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Herrera, Pilar (Hospital Universitario Ramon y Cajal) ; Garcia-Guinon, Antonni (Hospital Universitari Arnau de Vilanova de Lleida) ; Vall-Llovera, Ferran (Hospital Universitari MútuaTerrassa) ; Serrano, Josefina (Hospital Universitario Reina Sofia) ; Terol, Maria José (Hospital Clinico Universitario de Valencia) ; Bergua, Juan Miguel (Hospital San Pedro de Alcantara. Caceres) ; Garcia-Noblejas, Ana (Hospital Universitario de La Princesa) ; Barrenetxea, Cristina (Hospital Universitario Basurto) ; Llorente, Laura (Hospital Universitario HM Sanchinarro) ; Garcia-Belmonte, Daniel (Hospital Universitario La Zarzuela) ; Gimeno, Eva (Hospital del Mar (Barcelona, Catalunya)) ; Cladera, Antonia (Hospital Universitari Son Llatzer) ; Mercadal, Santiago (Institut Català d'Oncologia) ; Sancho, Juan Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
High dose-intensive or infusional intermediate-dose immunochemotherapy is highly effective treatment for Burkitt lymphoma irrespective of human immunodeficiency virus (HIV) infection. However, toxicities of these regimens are relevant, especially in older adults and elderly patients. [...]
2024 - 10.3324/haematol.2023.283342
Haematologica, Vol. 109 Núm. 2 (january 2024) , p. 543-552  
2.
4 p, 111.4 KB SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria / Griffin, Morag (Department of Hematology. St James University Hospitals) ; Eikema, Dirk-Jan (EBMT Statistical Unit) ; Verheggen, Inge (EBMT Leiden Study Unit) ; Kulagin, Alexander (Pavlov University) ; Tjon, Jennifer M-L (Department of Hematology. Leiden University Medical Center) ; Fattizzo, Bruno (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ; Ingram, Wendy (Department of Hematology. University Hospital of Wales) ; Zaidi, Uzma (National Institute of Blood Disease & Bone Marrow Transplantation) ; Desnica, Lana (Department of Hematology. University Hospital Center Zagreb) ; Giammarco, Sabrina (Dipartimento di Diagnostica per Immagini. Radioterapia Oncologica ed Ematologia. Fondazione Policlinico Universitario A. Gemelli IRCCS) ; Drozd-Sokolowska, Joanna (Department of Hematology. Medical University of Warsaw) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Patriarca, Andrea (Azienda Ospedaliero-Universitaria Maggiore della Carità and Translational Medicine Department. University of Eastern Piedmont) ; Loschi, Michael (Cote d'Azur University) ; Szmigielska-Kaplon, Anna (Department of Hematology. Copernicus Hospital) ; Beier, F. (RWTH Aachen University) ; Cignetti, Alessandro (University Division of Hematology) ; Drexler, Beatrice (Department of Hematology. University Hospital Basel) ; Gavriilaki, Eleni (Department of Hematology. George Papanicolaou General Hospital) ; Lanza, Francesco (Hospital Santa Maria delle Croci) ; Orvain, Corentin (Centre Hospitalier Universitaire d'Angers) ; Risitano, Antonio Maria (Department of Hematology. AORN Moscati) ; de la Camara, Rafael (Hospital Universitario de la Princesa (Madrid)) ; Peffault de Latour, Régis (Hôpital Saint-Louis)
2024 - 10.3324/haematol.2023.283863
Haematologica, Vol. 109 Núm. 1 (january 2024) , p. 283-286  
3.
7 p, 1.1 MB Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency / Marin-Bejar, Oskar (Institut d'Investigació Biomèdica de Bellvitge) ; Romero-Moya, Damia (Institut d'Investigació Biomèdica de Bellvitge) ; Rodriguez-Ubreva, Javier (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Distefano, Maximiliano (Hospital Sant Joan de Déu) ; Lessi, Francesca (Fondazione Pisana Per la Scienza ONLUS (FPS)) ; Aretini, Paolo (Fondazione Pisana Per la Scienza ONLUS (FPS)) ; Liquori, Alessandro (Instituto de Salud Carlos III) ; Castaño, Julio (Banc de Sang i Teixits) ; Kozyra, Emilia (University of Freiburg) ; Kotmayer, Lili (Semmelweis University. Budapest, Hungary) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Cervera, José (Hospital Universitari i Politècnic La Fe (València)) ; Rodriguez-Gallego, José Carlos (University of Las Palmas de Gran Canaria) ; Nomdedeu, Josep Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Murillo- Sanjuán, Laura (Vall d'Hebron Institut d'Oncologia) ; de Heredia, Cristina Díaz (Vall d'Hebron Institut d'Oncologia) ; Pérez-Martinez, Antonio (Universidad Autónoma de Madrid) ; López-Cadenas, Félix (Instituto Biosanitario de Salamanca (IBSAL)) ; Martínez-Laperche, Carolina (Hospital Gregorio Marañón. Instituto de Investigación Sanitaria) ; Dorado-Herrero, Nieves (Hospital Gregorio Marañón. Instituto de Investigación Sanitaria) ; Marco, Francisco M. (Institute for Health and Biomedical Research (ISABIAL)) ; Prósper, Felipe (Instituto de Salud Carlos III) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Valcárcel, David (Vall d'Hebron Institut d'Oncologia) ; Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bödör, Csaba (Semmelweis University. Budapest, Hungary) ; Bigas Salvans, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Catalá, Albert (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Wlodarski, Marcin W. (St. Jude Children's Research Hospital, Memphis, TN) ; Giorgetti, Alessandra (Institut d'Investigació Biomèdica de Bellvitge) ; Universitat Autònoma de Barcelona. Departament de Medicina
2023 - 10.3324/haematol.2022.282305
Haematologica, Vol. 108 Núm. 9 (september 2023) , p. 2551-2557  
4.
16 p, 4.7 MB BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases / Carbo-Meix, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Guijarro, Francesca (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Wang, Luojun (Hospital Clínic i Provincial de Barcelona) ; Grau, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Royo, Romina (Barcelona Supercomputing Center) ; Frigola, Gerard (Hospital Clínic i Provincial de Barcelona) ; Playa-Albinyana, Heribert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Buhler, Marco M. (University Hospital Zurich) ; Clot, Guillem (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Duran-Ferrer, Marti (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Lu, Junyan (European Molecular Biology Laboratory, Heidelberg) ; Granada, Isabel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Navarro, Jose Tomas (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Espinet, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ; Puiggros, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ; Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bandiera, Laura (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ; De Canal, Gabriella (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ; Bonoldi, Emanuela (Anatomia Istologia Patologica e Citogenetica. Dipartimento Ematologia. Oncologia e Medicina Molecolare. Niguarda Cancer Center, Milano) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Ribera-Cortada, Inmaculada (Hospital Nostra Senyora de Meritxell. Escaldes-Engordany. Principat d'Andorra) ; Fernandez-Caballero, Mariana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; De la Banda, Esmeralda (Institut d'Investigació Biomèdica de Bellvitge) ; Do Nascimento, Janilson (Hospital Joan XXIII, Institut Català d'Oncologia, Tarragona) ; Pineda, Alberto (Fundació Hospital de l'Esperit Sant) ; Vela, Dolors (Hematologia Clínica. Hospital General de Granollers) ; Rozman, Maria (Hospital Clínic i Provincial de Barcelona) ; Aymerich, Marta (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Syrykh, Charlotte (Cancer Institute University of Toulouse-Oncopole, France) ; Brousset, Pierre (Cancer Institute University of Toulouse-Oncopole, France) ; Perera, Miguel (Hospital Dr Negrín, Las Palmas de Gran Canaria) ; Yanez, Lucrecia (Hematology Department. Hospital Universitario Marqués de Valdecilla-Instituto de Investigación Valdecilla) ; Ortin, Jesus Xavier (Hematology Department. Hospital Verge de la Cinta) ; Tuset, Esperanza (Hospital Dr. Josep Trueta. Institut d'Investigació Biomèdica de Girona) ; Zenz, Thorsten (University Hospital and University of Zürich) ; Cook, James R. (Pathology and Laboratory Medicine Institute. Cleveland Clinic) ; Swerdlow, Steven H. (University of Pittsburgh School of Medicine) ; Martin-Subero, Jose I. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Colomer, Dolors (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Matutes, Estella (Hospital Clínic i Provincial de Barcelona) ; Bea, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Costa, Dolors (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Nadeu, Ferran (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Campo, Elias (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Universitat Autònoma de Barcelona. Departament de Medicina
The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. [...]
2024 - 10.3324/haematol.2023.283209
Haematologica, Vol. 109 Núm. 2 (february 2024) , p. 493-508  
5.
12 p, 4.8 MB Down syndrome and leukemia : from basic mechanisms to clinical advances / Baruchel, André (Hôpital Universitaire Robert Debré, Paris, France) ; Bourquin, Jean Pierre (University Children's Hospital, Zurich, Switzerland) ; Crispino, John (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Cuartero, Sergi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hasle, Henrik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Hitzler, Johann (The Hospital for Sick Children, Toronto, Canada) ; Klusmann, Jan Henning (Goethe University Frankfurt, Germany) ; Izraeli, Shai (Tel Aviv University, Tel Aviv, Israel) ; Lane, Andrew A. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Malinge, Sebastien (Cancer Centre, Perth, Western Australia) ; Rabin, Karen R. (University of Oxford, UK) ; Roberts, Irene (University of Oxford, UK) ; Ryeom, Sandra (Columbia University Irving Medical Center, New York, USA) ; Tasian, Sarah K. (University of Pennsylvania Perelman School of Medicine, Philadelphia, USA) ; Wagenblast, Elvin (Icahn School of Medicine at Mount Sinai, New York, USA)
Children with Down syndrome (DS, trisomy 21) are at a significantly higher risk of developing acute leukemia compared to the overall population. Many studies investigating the link between trisomy 21 and leukemia initiation and progression have been conducted over the last two decades. [...]
2023 - 10.3324/haematol.2023.283225
Haematologica, Vol. 108 Núm. 10 (october 2023) , p. 2570-2581  
6.
9 p, 1.0 MB Improved survival after acute graft-versus-host disease diagnosis in the modern era / Khoury, Hanna J. (Winship Cancer Institute of Emory University) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Couriel, Daniel (Utah Blood and Marrow Transplant) ; Alousi, Amin (The University of Texas MD Anderson Cancer Center) ; Cutler, Corey (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Battiwalla, Minoo (Lung and Blood Institute-NIH) ; Cahn, Jean Yves (University Hospital) ; Cairo, Mitchell (New York Medical College) ; Chen, Yi-Bin (Massachusetts General Hospital) ; Gale, Robert Peter (Imperial College London) ; Hashmi, Shahrukh (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Juckett, Mark (University of Wisconsin Hospital and Clinics) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Mohamed (H. Lee Moffitt Cancer Center and Research Institute) ; Litzow, Mark (Mayo Clinic Rochester) ; Majhail, Navnnet (Cleveland Clinic Taussig Cancer Institute) ; Miller, Alan (Baylor College of Medicine) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Qayed, Muna (Emory University School of Medicine) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Schouten, Harry C. (Academische Ziekenhuis) ; Socie, Gerard (Hopital Saint Louis) ; Storek, Jan (University of Calgary) ; Verdonck, Leo (Isala Clinics Zwolle) ; Vij, Ravi (Washington University School of Medicine) ; Wood, Willian A. (University of North Carolina) ; Yu, Lolie (Children's Hospital/Louisiana State University Medical Center) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Carabasi, Matthew (Thomas Jefferson University Hospital) ; Dandoy, Christopher (Cincinnati Children's Hospital Medical Center) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center) ; Hematti, Peiman (University of Wisconsin Hospital and Clinics) ; Solh, Melham (The Blood and Marrow Transplant Group of Georgia) ; Jamani, Kareem (University of Calgary) ; Lehmann, Leslie (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ; Savani, Bipin (Vanderbilt University Medical Center) ; Schultz, Kirk R. (The University of British Columbia) ; Wirk, Baldeep M. (Seattle Cancer Care Alliance) ; Spellman, Stephen (CIBMTR (Center for International Blood and Marrow Transplant Research)) ; Arora, Mukta (University of Minnesota Medical Center) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Universitat Autònoma de Barcelona
Acute graft-versus-host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted in improved outcome specifically among those diagnosed with acute graft-versus-host disease. [...]
2017 - 10.3324/haematol.2016.156356
Haematologica, Vol. 102 Núm. 5 (30 2017) , p. 958-966  
7.
9 p, 613.6 KB Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia : Primary analysis of the randomized, open-label mable study / Michallet, Anne-Sophie (CLCC Centre Léon Bérard) ; Aktan, Melih (Istanbul University) ; Hiddemann, Wolfgang (Ludwig- Maximilians University of Munich) ; Ilhan, Osman (Ankara University School of Medicine) ; Johansson, Peter (Uddevalla Hospital) ; Laribi, Kamel (Centre Hospitalier du Mans) ; Meddeb, Balkis (Aziza Othmana University Hospital) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Raposo, Joäo (Hospital de Santa Maria) ; Schuh, Anna (Oxford University Hospitals) ; Ünal, Ali (Erciyes University Medical School) ; Widenius, Tom (Peijas Hospital) ; Bernhardt, Alf (F. Hoffmann-La Roche Ltd) ; Kellershohn, Kerstin (Roche Pharma AG) ; Messeri, Dimitri (F. Hoffmann-La Roche Ltd) ; Osborne, Stuart (F. Hoffmann-La Roche Ltd) ; Leblond, Véronique (UPMC University) ; Universitat Autònoma de Barcelona
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic lymphocytic leukemia. Patients received rituximab plus bendamustine or rituximab plus chlorambucil every four weeks for six cycles. [...]
2018 - 10.3324/haematol.2017.170480
Haematologica, Vol. 103 Núm. 4 (23 2018) , p. 698-706  
8.
9 p, 996.2 KB Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia : Extended phase 3 results from RESONATE-2 / Barr, Paul M. (University of Rochester) ; Robak, Tadeusz (Medical University of Lodz) ; Owen, Carolyn (Tom Baker Cancer Centre) ; Tedeschi, Alessandra (ASST Grande Ospedale Metropolitano Niguarda) ; Bairey, Osnat (Sackler Faculty of Medicine. Tel Aviv University) ; Bartlett, Nancy L. (Washington University School of Medicine) ; Burger, Jan A. (University of Texas MD Anderson Cancer Center) ; Hillmen, Peter (The Leeds Teaching Hospitals. St. James Institute of Oncology) ; Coutre, Steven E (Stanford University School of Medicine) ; Devereux, Stephen (Kings College Hospital) ; Grosicki, Sebastian (School of Public Health. Silesian Medical University) ; McCarthy, Helen (Royal Bournemouth Hospital) ; Li, Jianyong (Jiangsu Province Hospital) ; Simpson, David (North Shore Hospital) ; Offner, Fritz (Universitair Ziekenhuis Gent) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Zhou, Cathy (Pharmacyclics. LLC an AbbVie Company) ; Styles, Lori (Pharmacyclics. LLC an AbbVie Company) ; James, Danelle (Pharmacyclics. LLC an AbbVie Company) ; Kipps, Thomas J (University of California,San Diego. Moores Cancer Center) ; Ghia, Paolo (Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele) ; Universitat Autònoma de Barcelona
Results of RESONATE-2 (PCYC-1115/1116) supported approval of ibrutinib for first-line treatment of chronic lymphocytic Rleukemia. Extended analysis of RESONATE-2 was conducted to determine long-term efficacy and safety of ibrutinib in older patients with chronic lymphocytic leukemia. [...]
2018 - 10.3324/haematol.2018.192328
Haematologica, Vol. 103 Núm. 9 (31 2018) , p. 1502-1510  
9.
9 p, 698.5 KB Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib : A GIMEMA, ERIC and UK CLL FORUM study / Cuneo, Antonio (St. Anna University Hospital) ; Follows, George (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Rigolin, Gian Matteo (St. Anna University Hospital) ; Piciocchi, Alfonso (Italian Group for Adult Hematologic Diseases (GIMEMA)) ; Tedeschi, Alessandra (Niguarda Cancer Center) ; Trentin, Livio (University of Padua) ; Perez, Angeles Medina (Hospital Costa del Sol (Marbella)) ; Coscia, Marta (University of Turin) ; Laurenti, Luca (Policlinico A. Gemelli) ; Musuraca, Gerardo (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)) ; Farina, Lucia (Fondazione IRCCS Istituto Nazionale Tumori) ; Delgado, Alfredo Rivas (Hospital Clínic i Provincial de Barcelona) ; Orlandi, Ester Maria (Fondazione IRCCS Policlinico San Matteo) ; Galieni, Piero (Ospedale C. e G. Mazzoni) ; Mauro, Francesca Romana ("Sapienza" University) ; Visco, Carlo (San Bortolo Hospital) ; Amendola, Angela (San Carlo Hospital) ; Billio, Atto (Azienda Sanitaria dell'Alto Adige) ; Marasca, Roberto (University of Modena and Reggio Emilia) ; Chiarenza, Annalisa (Azienda Universitaria Ospedaliera Policlinico Vittorio Emanuele) ; Meneghini, Vittorio (University Hospital) ; Ilariucci, Fiorella (Arcispedale S. Maria Nuova) ; Marchetti, Monia (Cardinal Massaia Hospital) ; Molica, Stefano (Azienda Ospedaliera Pugliese Ciaccio) ; Re, Francesca (University Hospital) ; Gaidano, Gianluca (Università del Piemonte Orientale Amedeo Avogadro) ; Gonzalez, Marcos (Hospital Universitari IBSAL i CIBERONC) ; Forconi, Francesco (University Hospital National Health Service Trust) ; Ciolli, Stefania (Careggi Hospital) ; Cortelezzi, Agostino (University of Milan) ; Montillo, Marco (Niguarda Cancer Center) ; Smolej, Lukas (University Hospital) ; Schuh, Anna (Oxford University Hospitals NHS Foundation Trust) ; Eyre, Toby A. (Oxford University Hospitals NHS Foundation Trust) ; Kennedy, Ben (University Hospitals of Leicester NHS Trust) ; Bowles, Kris M. (Norwich Medical School) ; Vignetti, Marco (Italian Group for Adult Hematologic Diseases (GIMEMA)) ; De La Serna, Javier (Hospital 12 de Octubre (Madrid)) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Foà, Robin ("Sapienza" University) ; Ghia, Paolo (IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University) ; Universitat Autònoma de Barcelona
We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PFS) was 25 months. [...]
2018 - 10.3324/haematol.2018.189837
Haematologica, Vol. 103 Núm. 7 (march 2018) , p. 1209-1217  
10.
9 p, 1.7 MB A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia / Onecha, Esther (Centro Nacional de Investigaciones Oncológicas) ; Linares, Maria (Centro Nacional de Investigaciones Oncológicas) ; Rapado, Inmaculada (Centro de Investigación Biomédica en Red de Cáncer) ; Ruiz-Heredia, Yanira (Centro Nacional de Investigaciones Oncológicas) ; Martinez-Sanchez, Pilar (Hospital Universitario 12 de Octubre) ; Cedena, Teresa (Centro Nacional de Investigaciones Oncológicas) ; Pratcorona, Marta (Institut d'Investigació Biomèdica Sant Pau) ; Oteyza, Jaime Perez (Hospital Universitario HM Sanchinarro (Madrid)) ; Herrera, Pilar (Hospital Universitario Ramón y Cajal (Madrid)) ; Barragán, Eva (Hospital Universitari i Politècnic La Fe (València)) ; Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ; Vela, Jose Antonio Garcia (Hospital Universitario de Getafe (Madrid)) ; Magro, Elena (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Anguita, Eduardo (Hospital Clínico San Carlos (Madrid)) ; Figuera, Angela (Hospital Universitario de la Princesa (Madrid)) ; Riaza, Rosalia (Hospital Universitario Severo Ochoa) ; Martinez-Barranco, Pilar (Hospital Universitario Fundación Alcorcón) ; Sanchez-Vega, Beatriz (Centro Nacional de Investigaciones Oncológicas) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; Gallardo, Miguel (Centro Nacional de Investigaciones Oncológicas) ; Martinez-Lopez, Joaquin (Centro Nacional de Investigaciones Oncológicas) ; Ayala, Rosa (Centro Nacional de Investigaciones Oncológicas) ; Universitat Autònoma de Barcelona
A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. [...]
2019 - 10.3324/haematol.2018.194712
Haematologica, Vol. 104 Núm. 2 (31 2019) , p. 288-296  

Dipòsit Digital de Documents de la UAB : 41 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.